{
    "code": "02022763",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022763",
    "time": "2020-02-07 03:27:26",
    "許可證字號": "衛署藥輸字第022763號",
    "註銷狀態": "已註銷",
    "註銷日期": "106\/09\/19",
    "註銷理由": "自請註銷",
    "有效日期": "109\/01\/18",
    "發證日期": "89\/01\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202276302",
    "中文品名": "&quot;理奧&quot; 低肝脂鈉２００００國際單位／毫升注射劑",
    "英文品名": "INNOHEP INJECTION 20000 ANTI-XAIU\/ML IN VIALS",
    "適應症": "治療深層靜脈栓塞、預防一般手術和骨科手術後產生深層靜脈栓塞、預防體外循環和血液透析時留置靜脈導管產生血塊、肺栓塞。",
    "劑型": "270注射劑",
    "包裝": "2公撮以下小瓶 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "0512001100  禾利行股份有限公司",
        "申請商地址": "台北市松山區敦化北路311號3樓",
        "主製造廠": ""
    },
    "CCC號列": "30019010002 肝素及其鹽類Heparin and its salts",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012401710",
            "成分名稱": "TINZAPARIN SODIUM",
            "含量描述": "",
            "含量": "20000.0000000000",
            "單位": "IU (I"
        }
    ],
    "仿單外盒": [
        {
            "title": "020227630001-104-08-20(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022763&Seq=004&Type=9"
        },
        {
            "title": "020227630003-Vial Label-104-09-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022763&Seq=004&Type=8"
        }
    ]
}